Chlamydia, determination of DNA (Chlamydia trachomatis, DNA) in prostate secretion, ejaculate

Rules for preparation for the study It is advisable to take the material before diagnostic and therapeutic manipulations in the supposed location of the pathogen. It is not recommended to take the biomaterial during antibacterial therapy.

In what cases is the analysis "Chlamydia, DNA detection in prostate secretion, ejaculate" carried out: acute phase of the disease; establishing the etiology of a chronic infectious process of the urogenital tract, including its upper sections, the possibility of detecting single molecules of DNA of a chlamydia cell, not detected by other methods; pregnancy with a burdened obstetric history; infertility; monitoring the effectiveness of therapy (not earlier than a month after the end of taking antibacterial drugs); preventive screening studies (to exclude the possibility of an asymptomatic course of infection).